New antibiotic compound very exciting, expert says
A new antibiotic compound could help treat a bacterium the World Health Organization classes as a major threat.
A new antibiotic compound could help treat a bacterium the World Health Organization classes as a major threat.
What is type 1 diabetes and what causes it? Type 1 diabetes can happen at any age, although the condition usually develops in children, teenagers, and young adults. Some people are more likely to develop this type of diabetes if other people in their family have the condition, or if they were exposed to an…
WASHINGTON — Amid tensions in the Middle East, Secretary of Defense Lloyd Austin was hospitalized, including spending four days in the intensive care unit, according to two senior administration officials. The Pentagon did not inform senior officials in the White House’s National Security Council of Austin’s hospitalization until Thursday — three days after he arrived…
A drug approved by the FDA over two decades ago for use in medical abortions and miscarriages is at risk of being pulled from the market after a decision by a Trump-appointed federal judge in Texas on Friday. However, a second federal judge in Washington state issued a competing ruling that would prohibit the FDA…
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies —…
As weight-loss medications like Ozempic and Wegovy peak in popularity moving into the New Year, semaglutide experts believe these meds could make it more likely that people will stick with their resolutions. (SEBASTIEN BOZON/AFP via Getty Images) STICKING WITH IT – Ozempic and other weight-loss drugs may strengthen New Year’s resolutions, experts say. Continue reading……
DealsHealth 17 November 2023, 11:31 am 1 minute Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant in Germany in the western town of Alzey for 2.3 billion euros ($2.5 billion), the U.S. drugmaker said on Friday, as the sector scrambles to meet soaring demand for new diabetes and obesity therapies. Market…